Technical Analysis for VRAY - ViewRay, Inc.

Grade Last Price % Change Price Change
grade A 8.69 1.28% 0.11
VRAY closed up 1.28 percent on Friday, May 24, 2019, on 46 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical VRAY trend table...

Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Wide Bands Range Expansion 1.28%
Overbought Stochastic Strength 1.28%
NR7 Range Contraction 1.05%
Wide Bands Range Expansion 1.05%
Overbought Stochastic Strength 1.05%
Wide Bands Range Expansion 0.35%
Overbought Stochastic Strength 0.35%

Older signals for VRAY ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
ViewRay, Inc. designs, manufactures, and markets radiation therapy systems worldwide. It offers MRIdian, a magnetic resonance imaging-guided radiation therapy system that images and treats cancer patients simultaneously. MRIdian integrates MRI technology, radiation delivery, and proprietary software to locate, target, and track the position and shape of soft-tissue tumors while radiation is delivered. The company markets its MRIdian through a direct sales force in the United States and distributors worldwide to a range of customers, including university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers. ViewRay, Inc. was founded in 2004 and is headquartered in Oakwood Village, Ohio.
Cancer Physical Sciences Radiation Applied Sciences Medical Physics Radiation Therapy Magnetic Resonance Imaging Radiobiology Magnetic Resonance
Is VRAY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 13.21
52 Week Low 4.86
Average Volume 1,169,295
200-Day Moving Average 8.0508
50-Day Moving Average 7.8392
20-Day Moving Average 8.0915
10-Day Moving Average 8.519
Average True Range 0.3386
ADX 28.98
+DI 25.249
-DI 16.5457
Chandelier Exit (Long, 3 ATRs ) 7.844199999999999
Chandelier Exit (Short, 3 ATRs ) 7.5758
Upper Bollinger Band 9.4001
Lower Bollinger Band 6.7829
Percent B (%b) 0.73
BandWidth 32.345053
MACD Line 0.2901
MACD Signal Line 0.2375
MACD Histogram 0.0526
Fundamentals Value
Market Cap 512.77 Million
Num Shares 59 Million
EPS -1.27
Price-to-Earnings (P/E) Ratio -6.84
Price-to-Sales 21.64
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.98
Resistance 3 (R3) 8.97 8.87 8.93
Resistance 2 (R2) 8.87 8.80 8.87 8.91
Resistance 1 (R1) 8.78 8.75 8.83 8.79 8.90
Pivot Point 8.68 8.68 8.70 8.68 8.68
Support 1 (S1) 8.59 8.61 8.64 8.60 8.48
Support 2 (S2) 8.49 8.56 8.49 8.47
Support 3 (S3) 8.40 8.49 8.45
Support 4 (S4) 8.41